Select Advisory Services
Select Legal Advisory Support for Pharmaceuticals & Life Sciences in Canada
Cura Law™ provides select legal advisory support where deep Canadian pharmaceutical and life sciences expertise is required. Advisory mandates are engaged on focused matters, whether complementing internal teams and external counsel or addressing standalone needs. Cura Law™ brings experienced judgment and regulatory fluency to operational and strategic decisions across pharmaceutical pricing and reimbursement, Health Canada regulation, patent strategy, and lifecycle compliance in Canada.
Clients rely on Cura Law™ for clear, jurisdiction-specific advice in Canada’s complex life sciences regulatory environment.
pharmaceuticals • biologics • biotechnology • medical devices • controlled substances • vaccines • natural health products • food
Areas of Focus
-
We advise on pharmaceutical pricing, including compliance with the Patented Medicines Regulations and Patented Medicines Prices Review Board (PMPRB) Guidelines. We help structure pricing and patent strategies to limit PMPRB purview or manage regulatory risk where jurisdiction applies, including alignment of patent portfolios and DIN-to-patent mapping, to inform launch and lifecycle pricing decisions. This ensures patented medicines achieve compliant and commercially effective pricing.
-
We provide legal guidance on drug reimbursement and market access, including formulary listing, formulary interchangeability and switching policies. We advise and negotiate product listing agreements (PLAs) with public plans and private insurers across Canada, and interpret guidance from pan-Canadian Pharmaceutical Alliance (pCPA), Canada’s Drug Agency (CDA), and INESSS to support access strategies and manage regulatory and compliance risk.
-
We provide legal guidance to help clients navigate Health Canada’s evolving regulatory regime and pharmaceutical laws. We advise on all regulated products throughout a product’s lifecycle (drug development to commercialization) — from clinical trial applications, manufacture, approval, labelling, importation, storage, sale, establishment license and post-market oversight — ensuring compliance with the Food and Drugs Act, relevant regulations, and Health Canada guidance and policies. We also support clients in responding to regulatory inquiries and addressing compliance challenges.
-
We assist with all aspects of product marketing and promotion across Canadian markets, helping companies navigate the complex rules governing promotional activities — including advertising, labeling, social and digital media, and interactions with healthcare professionals. We advise on compliance with the Food and Drugs Act, Health Canada guidance, and the guidelines of regulatory bodies such as the Pharmaceutical Advertising Advisory Board (PAAB), Advertising Standards Canada, the Competition Bureau, and industry codes such as Innovative Medicines Canada (IMC) Code of Ethical Practices. From reviewing packaging, promotional materials, and corporate websites to advising on digital content gating and linking, we provide practical guidance for compliant promotion and advertising.
-
We provide legal opinions on patent and drug regulatory issues including data protection for market exclusivity, patent portfolio management (including for PMPRB considerations), patent linkage and patent list eligibility under Patented Medicines (Notice of Compliance) Regulations, and patent term restoration through Certificates of Supplementary Protection.
-
We assist clients in identifying data within records (including adverse reaction reports) to be withheld from third-party disclosure. We prepare submissions to Health Canada or relevant provincial authorities to protect confidential and proprietary information, pursuant to the Privacy Act, the Access to Information Act, and applicable provincial privacy laws and regulations.
-
We advise clients on compliance with industry codes of practice and ethical standards, including the Innovative Medicines Canada (IMC) Code of Ethical Practices and the Pharmaceutical Advertising Advisory Board (PAAB) guidelines.
-
We provide legal guidance on the operations of pharmacies, including virtual settings, and address pharmacists’ scope of practice across jurisdictions. We advise on compliance with Health Canada, provincial laws, the College of Pharmacists, and the Competition Bureau, helping ensure compliant and commercially sound pharmacy operations and practice.
Advisory Engagements
Engaged directly by pharmaceutical and life sciences companies for focused Canadian regulatory and strategic matters, including for multinational companies navigating Canadian regulatory and pricing frameworks.
Advisory Support
Behind the Scenes Support for Law Firms & In-House Teams
Cura Law™ works directly with in-house legal teams and alongside external counsel, providing confidential, behind-the-scenes legal support on pharmaceutical and life sciences matters. Advisory support is available for jurisdiction-specific analysis, legal research, drafting of opinions and correspondence, and support on complex matters – including disputes and judicial reviews – for project-based or specialized mandates. Engagements are structured to integrate seamlessly with existing teams and respect all client relationships.
Conflicts
Cura Law™ provides independent, high-quality advice. All existing client relationships are respected, and strict confidentiality is maintained throughout and after every mandate.
Independent, trusted counsel when conflicts arise.
Why Expertise Matters
The pharmaceutical and life sciences landscape in Canada is highly complex, governed by intersecting laws, regulations, guidance and policies across multiple layers of oversight:
Federal
Health Canada approvals, data protection, patent linkage (PM(NOC)), advertising, and pricing of patented medicines (PMPRB)
Provincial
Pricing, reimbursement and formulary management
Industry Associations
Codes of practice and ethical standards
Cura Law™ combines life sciences experience, legal expertise, commercial acumen and practical guidance to deliver actionable counsel that drives strategic decisions. Engaging a niche, specialized firm ensures your team benefits from:
Regulatory compliance (Health Canada, Food and Drugs Act), patent strategy (Patent Act, PM(NOC) Regulations), and market access (PMPRB, pCPA) and related frameworks
Timely, practical advice tailored to industry realities
Connecting legal developments to business impact
Expand your capacity and access sector-specific expertise with Cura Law™.
The Capsule™ operates independently as an ongoing legal and regulatory intelligence platform designed to support internal assessment and prioritization.Cura Law™ advisory services are provided on a limited basis and independently of the Capsule™.